Suppr超能文献

用于透明边缘变性患者视力康复的巩膜Misa镜片的临床结果

Clinical outcomes of scleral Misa lenses for visual rehabilitation in patients with pellucid marginal degeneration.

作者信息

Asena Leyla, Altınörs Dilek Dursun

机构信息

Baskent University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey.

Baskent University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey.

出版信息

Cont Lens Anterior Eye. 2016 Dec;39(6):420-424. doi: 10.1016/j.clae.2016.06.010. Epub 2016 Jul 16.

Abstract

PURPOSE

To report the clinical outcomes of scleral Misa lenses (Microlens Contactlens Technolgy, Arnhem, Netherlands) for visual rehabilitation in patients with pellucid marginal degeneration (PMD).

MEHODS

In this prospective interventional case series, 24 eyes of 12 PMD patients were fitted with scleral Misa lenses. Patients were followed regularly for continuous daily wearing time (CDWT), contact lens handling issues, visual acuity, and any subjective or objective contact lens related complications.

RESULTS

The mean patient age was 35.0±13.8 years (range, 23-47 years). The average length of follow-up was 14.1±3.7 months (range, 8.5-18 months). All eyes were fit with mini Misa scleral lenses with a diameter of 16.5 or 17mm. The mean Snellen best-corrected visual acuity (BCVA) before scleral lenses with spectacle correction was 0.42±0.15 (range, 0.2-0.6). With scleral lenses, mean BCVA was 0.75±0.15 (range, 0.5-0.9), (p=0.003) with a mean gain of 3.3 lines of BCVA. More than half (16 eyes, 67%) reported wearing their scleral lenses for 8h or more on a daily basis. Three patients (6 eyes, 25%) abandoned scleral lens wear. Patients who abandoned the scleral lens wear tended to have a better spectacle corrected visual acuity and less gain of lines.

CONCLUSIONS

Scleral lenses can be used succesfully in patients with PMD who are intolerant to other types of contact lenses. Patients who have a low spectacle BCVA and a higher gain of visual acuity with scleral lenses are good candidates for scleral lens use.

摘要

目的

报告巩膜Misa镜片(荷兰阿纳姆Microlens Contactlens Technolgy公司)用于透明边缘变性(PMD)患者视力康复的临床结果。

方法

在这个前瞻性干预性病例系列中,为12例PMD患者的24只眼佩戴巩膜Misa镜片。定期随访患者的连续每日佩戴时间(CDWT)、隐形眼镜处理问题、视力以及任何与隐形眼镜相关的主观或客观并发症。

结果

患者平均年龄为35.0±13.8岁(范围23 - 47岁)。平均随访时间为14.1±3.7个月(范围8.5 - 18个月)。所有眼睛均佩戴直径为16.5或17mm的迷你Misa巩膜镜片。佩戴巩膜镜片前,使用框架眼镜矫正时的平均Snellen最佳矫正视力(BCVA)为0.42±0.15(范围0.2 - 0.6)。佩戴巩膜镜片后,平均BCVA为0.75±0.15(范围0.5 - 0.9),(p = 0.003),平均BCVA提高了3.3行。超过一半(16只眼,67%)的患者报告每天佩戴巩膜镜片8小时或更长时间。3例患者(6只眼,25%)放弃佩戴巩膜镜片。放弃佩戴巩膜镜片的患者框架眼镜矫正视力往往较好,视力提高的行数较少。

结论

巩膜镜片可成功用于不耐受其他类型隐形眼镜的PMD患者。框架眼镜BCVA低且佩戴巩膜镜片后视力提高较多的患者是使用巩膜镜片的良好候选者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验